Staging of the Axilla in Breast Cancer and the Evolving Role of Axillary Ultrasound

Michael Y Chen,1 William E Gillanders1,2 1Department of Surgery, Washington University, St Louis, MS, USA; 2Siteman Cancer Center in St. Louis, St Louis, MS, USACorrespondence: William E GillandersSiteman Cancer Center in St. Louis, 660 South Euclid Avenue Campus Box 8109, St Louis, MS, 63110, USATe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chen MY, Gillanders WE
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/74bf8ffc35e7479f8d32e70d39753021
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:74bf8ffc35e7479f8d32e70d39753021
record_format dspace
spelling oai:doaj.org-article:74bf8ffc35e7479f8d32e70d397530212021-12-02T14:43:49ZStaging of the Axilla in Breast Cancer and the Evolving Role of Axillary Ultrasound1179-1314https://doaj.org/article/74bf8ffc35e7479f8d32e70d397530212021-05-01T00:00:00Zhttps://www.dovepress.com/staging-of-the-axilla-in-breast-cancer-and-the-evolving-role-of-axilla-peer-reviewed-fulltext-article-BCTThttps://doaj.org/toc/1179-1314Michael Y Chen,1 William E Gillanders1,2 1Department of Surgery, Washington University, St Louis, MS, USA; 2Siteman Cancer Center in St. Louis, St Louis, MS, USACorrespondence: William E GillandersSiteman Cancer Center in St. Louis, 660 South Euclid Avenue Campus Box 8109, St Louis, MS, 63110, USATel +1 314 747 0072Email gillandersw@wustl.eduAbstract: Axillary lymph nodes have long been recognized as a route for breast cancer to spread systemically. As a result, staging of the axilla has always played a central role in the treatment of breast cancer. Anatomic staging was believed to be important for two reasons: 1) it predicts prognosis and guides medical therapy, and 2) it is a potential therapy for removal of disease in the axilla. This paradigm has now been called into question. Prognostic information is driven increasingly by tumor biology, and trials such as the ACOSOG Z0011 demonstrates removal of axillary disease is not therapeutic. Staging of the axilla has undergone a dramatic de-escalation; however, sentinel lymph node biopsy (SLNB) is still an invasive surgery and represents a large economic burden on the healthcare system. In this review, we outline the changing paradigms of axillary staging in breast cancer from emphasis on anatomic staging to tumor biology, and the evolving role of axillary ultrasound, bringing patients less invasive and more personalized therapy.Keywords: breast cancer, axillary staging, SLNB, ALND, axillary ultrasound, Z0011Chen MYGillanders WEDove Medical Pressarticlebreast canceraxillary stagingslnbalndaxillary ultrasoundz0011Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENBreast Cancer: Targets and Therapy, Vol Volume 13, Pp 311-323 (2021)
institution DOAJ
collection DOAJ
language EN
topic breast cancer
axillary staging
slnb
alnd
axillary ultrasound
z0011
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle breast cancer
axillary staging
slnb
alnd
axillary ultrasound
z0011
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Chen MY
Gillanders WE
Staging of the Axilla in Breast Cancer and the Evolving Role of Axillary Ultrasound
description Michael Y Chen,1 William E Gillanders1,2 1Department of Surgery, Washington University, St Louis, MS, USA; 2Siteman Cancer Center in St. Louis, St Louis, MS, USACorrespondence: William E GillandersSiteman Cancer Center in St. Louis, 660 South Euclid Avenue Campus Box 8109, St Louis, MS, 63110, USATel +1 314 747 0072Email gillandersw@wustl.eduAbstract: Axillary lymph nodes have long been recognized as a route for breast cancer to spread systemically. As a result, staging of the axilla has always played a central role in the treatment of breast cancer. Anatomic staging was believed to be important for two reasons: 1) it predicts prognosis and guides medical therapy, and 2) it is a potential therapy for removal of disease in the axilla. This paradigm has now been called into question. Prognostic information is driven increasingly by tumor biology, and trials such as the ACOSOG Z0011 demonstrates removal of axillary disease is not therapeutic. Staging of the axilla has undergone a dramatic de-escalation; however, sentinel lymph node biopsy (SLNB) is still an invasive surgery and represents a large economic burden on the healthcare system. In this review, we outline the changing paradigms of axillary staging in breast cancer from emphasis on anatomic staging to tumor biology, and the evolving role of axillary ultrasound, bringing patients less invasive and more personalized therapy.Keywords: breast cancer, axillary staging, SLNB, ALND, axillary ultrasound, Z0011
format article
author Chen MY
Gillanders WE
author_facet Chen MY
Gillanders WE
author_sort Chen MY
title Staging of the Axilla in Breast Cancer and the Evolving Role of Axillary Ultrasound
title_short Staging of the Axilla in Breast Cancer and the Evolving Role of Axillary Ultrasound
title_full Staging of the Axilla in Breast Cancer and the Evolving Role of Axillary Ultrasound
title_fullStr Staging of the Axilla in Breast Cancer and the Evolving Role of Axillary Ultrasound
title_full_unstemmed Staging of the Axilla in Breast Cancer and the Evolving Role of Axillary Ultrasound
title_sort staging of the axilla in breast cancer and the evolving role of axillary ultrasound
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/74bf8ffc35e7479f8d32e70d39753021
work_keys_str_mv AT chenmy stagingoftheaxillainbreastcancerandtheevolvingroleofaxillaryultrasound
AT gillanderswe stagingoftheaxillainbreastcancerandtheevolvingroleofaxillaryultrasound
_version_ 1718389576578367488